Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 55,410 | 25,160 | 18,400 | 13,080 | 10,902 |
| Cost of Goods | 3,600 | 3,670 | 2,370 | 2,160 | N/A |
| Gross Profit | 51,800 | 21,490 | 16,030 | 10,920 | 10,902 |
| Operating Expenses | 43,560 | 26,850 | 16,590 | 14,230 | 0 |
| Operating Income | 8,850 | -4,690 | -190 | -3,150 | 10,902 |
| Interest Expense | 40 | 20 | 40 | 0 | 0 |
| Other Income | 480 | 720 | 2,680 | 290 | 0 |
| Pre-tax Income | 9,290 | -3,990 | 2,450 | -2,860 | 10,902 |
| Income Tax | -3,200 | -500 | -550 | 10 | N/A |
| Net Income Continuous | 12,026 | -3,330 | 705 | -2,874 | -4,884 |
| Net Income Discontinuous | 0 | 0 | 0 | 0 | -4,577 |
| Net Income | $12,490 | $-3,490 | $3,000 | $-2,870 | $-9,461 |
| EPS Basic Total Ops | 0.56 | -0.19 | 0.19 | -0.18 | -0.62 |
| EPS Basic Continuous Ops | 0.56 | -0.19 | 0.04 | -0.18 | -0.32 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.30 |
| EPS Diluted Total Ops | 0.51 | -0.19 | 0.18 | -0.18 | -0.62 |
| EPS Diluted Continuous Ops | 0.51 | -0.19 | 0.04 | -0.18 | -0.32 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.30 |
| EBITDA(a) | $11,380 | $-2,980 | $1,270 | $-3,150 | $10,902 |